Frontlight ResearchEarly access
Trial site
Omsk
- 4closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Diabetic eye disease1 trial
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Melanoma1 trial
- Phase
- Phase 34 trials
- Status
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
Closed trials
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026